These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1451237)

  • 1. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
    Bishop FE; Dive C; Freeman S; Gescher A
    Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
    Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
    Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antitumoral activity of alkylphosphonates.
    Ries UJ; Fleer EA; Breiser A; Unger C; Stekar J; Fenneberg K; Eibl H
    Eur J Cancer; 1992; 29A(1):96-101. PubMed ID: 1445752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C; Berger MR; Schuler B; Scherf HR; Garzon FT; Zeller WJ; Unger C; Eibl HJ; Schmähl D
    Lipids; 1987 Nov; 22(11):930-4. PubMed ID: 3444388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of enantio-selectivity in the in vitro antitumour cytotoxicity and membrane-damaging activity of ether lipid SRI 62-834: further evidence for a non-receptor-mediated mechanism of action.
    Lohmeyer M; Workman P
    Biochem Pharmacol; 1992 Aug; 44(4):819-23. PubMed ID: 1510728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
    Fleer EA; Berkovic D; Grunwald U; Hiddemann W
    Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
    Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
    J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.
    Lohmeyer M; Workman P
    Biochem Pharmacol; 1993 Jan; 45(1):77-86. PubMed ID: 8424826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
    Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
    Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexadecylphosphocholine differs from conventional cytostatic agents.
    Berger MR; Betsch B; Gebelein M; Amtmann E; Heyl P; Scherf HR
    J Cancer Res Clin Oncol; 1993; 119(9):541-8. PubMed ID: 8392075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834.
    Lazenby CM; Thompson MG; Hickman JA
    Cancer Res; 1990 Jun; 50(11):3327-30. PubMed ID: 2334926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the ether phospholipid AMG-PC on mast cells are similar to that of the ether lipid AMG but different from that of the analogue hexadecylphosphocholine.
    Grosman N
    Immunopharmacology; 1991; 22(1):39-47. PubMed ID: 1791141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
    Lohmeyer M; Workman P
    Br J Cancer; 1995 Aug; 72(2):277-86. PubMed ID: 7640206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
    Magistrelli A; Villa P; Benfenati E; Modest EJ; Salmona M; Tacconi MT
    Drug Metab Dispos; 1995 Jan; 23(1):113-8. PubMed ID: 7720513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB; Berger MR
    Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
    Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
    Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity.
    Goppelt-Struebe M; Winter I
    Cancer Chemother Pharmacol; 1995; 35(6):519-26. PubMed ID: 7882461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.